Significance of the menopause

Practice Nurse

Volumn 41, Issue 2, 2011, Pages 27-30

  Munson, Eileen ^a  

^a UNIVERSITY OF GLAMORGAN   (United Kingdom)

Author keywords

Breast cancer; Hormone replacement therapy; Menopause; Oestrogen deficiency; Women's health

Indexed keywords

EID: 79952135494     PISSN: 09536612     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (28)

1. Pitkin J. Cultural issues and the menopause. Menopause Int 2010; 16(4): 156-61.
2. Utian WH. The International Menopause Society menopause-related terminology definitions. Climacteric 1999; 6:167-73.
3. Nursing & Midwifery Council. The proposed framework for the standard for post-registration nursing - February 2005. London: NMC, 2005. www.nmc-uk.org/Get-involved/Consultations/Past-consultations/By-year/ The-proposed-framework-for-the-standard-for-post-registration-nursing-February- 2005 (accessed 24/01/11).
4. Nursing & Midwifery Council. Standards for proficiency for nurse and midwife prerscribers. Practice Standard 1 'Licence as a presciber'. London: NMC, 2006.
5. Royal College of Nursing. Women's health and the menopause. RCN guidance for nurses, midwives and health visitors. London: RCN, 2005.
6. National Prescribing Centre. An outline framework to help nurses prescribe. Liverpool: NPC, 2001.
7. National Prescribing Centre. Maintaining competency in prescribing. An outline framework to help nurses prescribers. Liverpool: NPC, 2001.
8. National Prescribing Centre. Training non-medical prescribers in practice. Liverpool: NPC, 2005.
9. MacLennan A, Lester S, Moore V. Oral estrogen replacement therapy versus placebo for hot flushes: a systemic review. Climacteric 2001; 4: 58-74. (Pubitemid 32448488)
10. Cardozo L, Lose G, McClish D et al. Metaanalysis of estrogen therapy in urinary tract infections: third report of the Hormones and Urogenital Therapy (HUT) Committee. Int Urogynecol J Pelvic Floor Dysfunction 2001; 12: 271-8.
11. Honjo H, Iwasa K, Urabe M. Clinical studies of oestrogen therapy for dementia. J Br Menopause Soc 1998; 1:26-8.
12. Paganini-Hill A. Estrogen replacement therapy and colorectal cancer risk in elderly women. Dis Colon Rectum 1999; 42(10): 1300-5. (Pubitemid 29489363)
13. Soares CN, Almeida OP, Joffe H, Cohen L.S. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double blind, randomized, placebo-controlled trail. Arch Gen Psychiatry 2001; 58: 529-34. (Pubitemid 32523731)
14. Royal College of Physicians. Osteoporosis: clinical guidelines for prevention and treatment. London: RCP, 1999.
15. Royal College of Physicians. Osteoporosis: clinical guidelines for prevention and treatment. Update on pharmacological intervention and algorithm for management. London: RCP, 2000.
16. Torgerston D, Bell-Syer S. Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials. J Am Med Assoc 2001; 285: 2891-7. (Pubitemid 32537354)
17. Women's Health Initiative Steering Committee. Effects of conjugated equine oestrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2004; 291: 1701-12.
18. Writing group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002; 288: 321-33.
19. Beral V, Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362: 419-27. (Pubitemid 36999703)
20. Whitehead M, Farmer R. The Million Women Study: a critique. Endocrine 2004; 24: 187-93. (Pubitemid 41271148)
21. British Menopause Society. Database of clinics in the United Kingdom. British Menopause Society, 2006.
22. Cassidy A. Diet and menopause health. Prim Health Care 2005; 14(5): 41-9.
23. Office for National Statistics. Mortality statistics (cause). Review of the Registrar General on deaths by cause, sex and age in England and Wales in 2008. ONS, 2010.
24. Chlebowski RT, Anderson GL, Grass M et al. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. J Am Med Assoc 2010; 304(15): 1684-92.
25. Brown S. WHI now reports risk of breast cancer mortality from combined HRT use. Menopause. News and views from editor. Menopause Int 2010; 16: 136-8.
26. Beral V. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies, 52 705 women with breast cancer and 108 411 women without breast cancer. Lancet 1997; 305:1047-59. (Pubitemid 27437855)
27. Committee on Safety of Medicine. Further advice on safety of HRT: risk and benefits unfavourable for first line use in prevention of osteoporosis. CEM/CMO/2003/19. CSM, 2003.
28. Beral V, Banks E, Reeves G. Hormone replacement therapy and high incident of breast cancer between mammographic screening. Lancet 1997; 349(9058): 1103-4. (Pubitemid 27158270)